3-Bromo-5-isopropyl-1,2,4-oxadiazole, 95.0%, 250mg

4-BROMO-2-FLUOROPYRIDINE-3-CARBOXYLIC ACID, 95.0%, 1g

(-)-Di-p-Toluoyl-L-tartaric acid, 99.0%, 500g

Cubeta de muestra SpecTainer, 60 ml, Estéril, 500 Pieza(s)

(R)-2-((tert-Butoxycarbonyl)amino)-2-(thiophen-2-yl)acetic acid, 95.0%, 1g

tert-Butyl 2-iodo-7-azaspiro[3.5]nonane-7-carboxylate, 98%, 5g

N-(((9H-fluoren-9-yl)methoxy)carbonyl)-S-(tert-butylthio)-D-cysteine, 95+%, 25g

Octyl butyrate, 98+%, 100g

1,2,3,6-Tetrahydro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1-(2,2,2-trifluoroethyl)-pyridine, 98%, 5g

N-(2,4-Dimethylphenyl)acetamide, 95.0%, 250mg

1-(5-Bromothiazol-2-yl)ethanone, 95.0%, 5g

Sulfato de samario anhidro en polvo 99,9% 25 g

Ethyl 2-[4-chloro-3-(trifluoromethyl)phenoxy]-acetate, 1g